FDA asks Pfizer to further evaluate Chantix
Chantix is used as a smoking cessation medicine which works in the brain to block the pleasurable effects of smoking. The results from a randomized trial involving 700
Exegenesis Bio and Modalis Therapeutics have entered a research partnership and licence agreement to progress MDL-201, a therapeutic candidate for Duchenne muscular dystrophy (DMD).